USOR 24188 - Ph3 multisite randomized trial of BNT327 in combo with participants with SCLC

A Phase III, multisite, double-blinded randomized trial of BNT327 in combination with chemotherapy (etoposide/carboplatin) compared to atezolizumab in combination with chemotherapy (etoposide/carboplatin) in participants with first-line extensive-stage small-cell lung cancer

Disease Types: Lung - Small Cell Lung

Available at: Arlington Heights, Chicago, Niles